Review Article

Severity and Mortality Associated with Steroid Use among Patients with COVID-19: A Systematic Review and Meta-Analysis

Table 3

Methodological quality assessment.

Newcastle–Ottawa scale (NOS)
StudiesSelectionComparabilityOutcomeQuality score
ABcdefgh

Fadel et al. [17]8
Guan et al. [27]9
Huang et al. [24]8
Li et al. [12]6
Ling et al. [25]6
Shang et al. [18]6
Yang et al. [22]6
Wang et al. [19]6
Wu et al. [21]7
Zhao et al. [26]6
Zhou et al. [23]7
Borie et al. [28]6
Falcone et al. [43]7
Fernández-Cruz et al. [29]7
Krishnan et al. [30]6
Li et al. [31]6
Papamanoli et al. [32]7
You et al. [33]6
Rodríguez-Baño et al. [34]7
Ma, Q et al. [35]7
Lu et al. [36]7
Cao et al. [37]6
Nelson et al. [38]7
Bani-Sadr et al. [39]6
Salton et al. [40]7
Mikulska et al. [41]6
Majmundar et al. [42]7

Cochrane risk of bias tool
IJklmn
Horby et al. [44]Low risk of biasLow risk of biasHigh risk of biasUnclear risk of biasLow risk of biasLow risk of bias
Angus et al. [45]Low risk of biasLow risk of biasHigh risk of biasLow risk of biasLow risk of biasLow risk of bias
Dequin et al. [46]Low risk of biasHigh risk of biasHigh risk of biasLow risk of biasLow risk of biasLow risk of bias
Jeronimo et al. [47]Low risk of biasLow risk of biasHigh risk of biasLow risk of biasLow risk of biasLow risk of bias

a: representativeness of the exposed cohort, b: selection of the nonexposed cohort, c: ascertainment of exposure, d: demonstration that the outcome of interest was not present at the start of the study, e: comparability of cohorts based on the design or analysis, f: assessment of outcome, g: follow-up long enough for outcomes to occur, h: adequacy of follow-up of the cohort; i: random sequence generation (selection bias), j: allocation concealment (selection bias), k: blinding of participants and personnel (performance bias), l: blinding of outcome assessment (detection bias), m: incomplete outcome data (attrition bias), n: selective reporting (reporting bias).